US2016339027A1PendingUtilityA1
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
Est. expiryJan 12, 2018(expired)· nominal 20-yr term from priority
Inventors:Malcolm Clive CarterGeorge Stuart CockerillKaren Elizabeth LackeyStephen Barry GuntripKathryn Jane Smith
A61P 9/10A61P 37/00A61P 9/00A61P 43/00A61P 29/00A61P 31/00A61P 3/10A61P 35/00A61P 17/06A61P 17/00C07D 417/14C07D 239/94C07D 405/04C07D 417/04C07D 405/14C07D 471/04C07D 411/04A61K 31/517A61K 31/519
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pharmaceutical formulation comprising the compound of formula
Claims
exact text as granted — not AI-modified1 . A method of treating non-small cell lung cancer in a human or animal subject mammal, comprising administering to said subject an effective amount of the compound of formula (I)
or a pharmaceutically acceptable salt or solvate thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.